000 01029 a2200301 4500
005 20250511183606.0
264 0 _c19921222
008 199212s 0 0 eng d
022 _a0828-282X
040 _aNLM
_beng
_cNLM
100 1 _aDavignon, J
245 0 0 _aHMG-CoA reductase inhibitors: a look back and a look ahead.
_h[electronic resource]
260 _bThe Canadian journal of cardiology
_cOct 1992
300 _a843-64 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDrug Interactions
650 0 4 _aDrug Therapy, Combination
650 0 4 _aDrug Tolerance
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl CoA Reductases
_xphysiology
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
650 0 4 _aHyperlipoproteinemia Type II
_xdrug therapy
650 0 4 _aHypolipidemic Agents
_xadverse effects
700 1 _aMontigny, M
700 1 _aDufour, R
773 0 _tThe Canadian journal of cardiology
_gvol. 8
_gno. 8
_gp. 843-64
999 _c1429494
_d1429494